NEET UG 2025 provisional answer key out, raise objections by June 5
NEW DELHI: The National Testing Agency (NTA) on Tuesday released the provisional answer keys for the National Eligibility-cum-Entrance Undergraduate (NEET UG) 2025 exam held on May 4.
An official release said that the candidates who appeared for the exam, which decides admissions in undergraduate courses in medical and allied streams, can download these answer keys from the official NTA website (neet.nta.nic.in). The scanned copies of the response sheets submitted by the candidate too are available in order to help students arrive at a rough estimate of their score. NTA is expected to release the results and announce the All India Ranks by June 14.
The release said the candidates are also permitted to contest the answers and submit their challenges online. The answer key challenge window will remain open from June 3 to June 5. A fee of Rs 200 needs to be paid for any challenge posed by the student.
A total of 20.87 lakh students appeared for the exam at 4,750 centres in India and 14 centres abroad. The question paper consisted of 180 questions split equally between Physics, Chemistry and Biology.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
23 minutes ago
- India Today
14-day visa-free entry boosts Philippines as top choice for Indian medical students
With NEET UG 2025 results approaching, limited seats and high fees are pushing students abroad. The Philippines stands out for its newly announced 14-day visa-free entry for Indian nationals, making campus visits and initial enrolment hassle-free. Along with affordable tuition and internationally recognised medical degrees, classes are taught in English and students gain early hands-on clinical training. A growing Indian community on campus also makes settling in Pillai, Managing Director, Transworld Educare has shared how these factors combine to make the Philippines a practical and welcoming option for medical ACCESS: SIMPLIFYING THE JOURNEYHere's a game-changer: visa-free entry for Indian nationals into the Philippines. This isn't just about cutting red tape; it simplifies the journey. Students and parents can visit campuses, attend orientations, and experience the environment without the stress of visa delays. This ease of movement boosts student mobility, allowing families to get firsthand insights - a valuable step when making a major decision about studying FEES: A SMART INVESTMENT COMPARED TO INDIA Let's talk finances, often the biggest hurdle. Private medical colleges in India can come with eye-watering costs that rise every year. The Philippines offers a far more affordable structure without compromising on quality. Tuition typically ranges between Rs 22 lakhs to Rs 31 lakhs for the full programme, depending on the university. Add savings from visa-free travel, and the overall value becomes hard to ignore for families seeking quality and RECOGNISED MEDICAL COLLEGES: WHO AND NMC ACCREDITATIONadvertisementQuality assurance is essential when choosing a medical school abroad. The Philippines is home to many institutions recognised by the World Health Organisation (WHO) and India's National Medical Commission (NMC). This dual recognition ensures your degree is valid in India and globally. Graduates are eligible for the Foreign Medical Graduate Examination (FMGE) in India and international exams like the USMLE - opening doors to medical careers both at home and CURRICULUM AND GLOBAL EXAM COMPATABILITYFor Indian students, here's a big plus: medical education in the Philippines is entirely in English. This eliminates language barriers and allows students to focus on academics. The American-style MD programme aligns with global standards and licencing exams like FMGE and USMLE. This structure ensures Indian students are well-prepared to practice medicine in India, the US, or CLINICAL EXPOSURE AND PRACTICAL TRAININGUnlike countries where clinical exposure is delayed, the Philippines emphasises hands-on training early in the program. Students engage with real patients and healthcare settings from the start. This early exposure builds confidence and strengthens practical skills. The American-model program blends theoretical knowledge with real-world application, preparing students for the demands of modern medicine.-----Another reassuring element: the large Indian student community in the Philippines. With thousands of Indian students already enrolled, new arrivals benefit from built-in support. Peer groups and student associations help ease cultural transitions and offer guidance on everything from academics to everyday life. The presence of Indian societies provides a warm welcome - something reassuring for many students and parents during this major life Indian students continue to explore global opportunities for medical education, the Philippines stands out. It combines visa-free access, affordability, recognised quality, and a strong support network. With its student-friendly policies and international credibility, the Philippines is emerging not just as an alternative, but as a preferred destination for Indian medical Reel
Business Standard
an hour ago
- Business Standard
Glenmark Pharma rises after zanubrutinib launch in India
Glenmark Pharmaceuticals rose 1% to Rs 1605.80 after the drug maker announced the upcoming launch of zanubrutinib in India, following approval from the Drugs Controller General of India (DCGI). Co-developed with global oncology leader BeOne Medicines, zanubrutinib will be marketed under the brand name Brukinsa. It is the first and only Brutons tyrosine kinase (BTK) inhibitor approved in India for five types of B-cell malignancies: chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Waldenstr macroglobulinemia (WM), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), and follicular lymphoma (FL). Globally, Brukinsa is approved in over 70 countries, backed by robust clinical evidence from pivotal trials such as Alpine, Aspen, and Sequoia. The drug has shown a strong safety profile, high response rates, and durable disease control. With one Indian diagnosed with blood cancer every five minutes and around 70,000 deaths annually, Brukinsa addresses a critical treatment gap. Its flexible dosing (once or twice daily) supports personalized care. In the Alpine study for relapsed/refractory CLL, Brukinsa reported significantly fewer serious cardiac events (1.9% vs 7.7%) and lower treatment discontinuation (0.3% vs 4.3%) compared to ibrutinib. Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. On a consolidated basis, Glenmark Pharmaceuticals reported net profit of Rs 4.65 crore in Q4 March 2025 as against net loss of Rs 1218.28 crore in Q4 March 2024. Net sales rose 6.77% year-on-year to Rs 3220.13 crore in Q4 March 2025.
The Wire
2 hours ago
- The Wire
Why India Needs to Update Its Own Poverty Line
Menu हिंदी తెలుగు اردو Home Politics Economy World Security Law Science Society Culture Editor's Pick Opinion Support independent journalism. Donate Now Economy Why India Needs to Update Its Own Poverty Line Dipa Sinha 4 minutes ago It is important to remember that poverty ratios derived from consumption-expenditure-based poverty lines represent only one dimension of well-being. Illustration: Pariplab Chakraborty Real journalism holds power accountable Since 2015, The Wire has done just that. But we can continue only with your support. Contribute now India's poverty numbers are once again making headlines, ironically even though our official poverty lines have not been updated in over a decade. The World Bank has revised the International Poverty Line (IPL) from $2.15/day (2017 purchasing power parity or PPP) to $3.00/day (2021 PPP). Based on this new line, the poverty ratio in India is estimated to be 5.25% compared to 27.12% in 2011-12. While it could be true that the poverty ratio has declined in the last decade, there are a number of questions related to the data and methodology which put a cloud over both the extent of decline as well as the level of poverty currently. A longstanding criticism that these poverty lines of the World Bank are extremely low and do not reflect what most would accept as absolute poverty still holds. Based on the latest data from the International Comparison Program (ICP) based on which these new estimates have been released, one PPP$ is roughly equivalent to Rs 20. Therefore, this new poverty line of $3 a day reflecting extreme poverty is equivalent to only Rs 60 per day of consumption expenditure per person. On the basis of the higher IPL of $4.2 PPP (i.e. Rs 84) per day, 23.89% Indians are estimated to be poor. We don't need to be experts to imagine what living on less than Rs 84 a day means (this is to account for all expenses of a person including rent, travel, food, education, health and other consumption). It is common practice for poverty lines to be revised at regular intervals to reflect the change in living standards and consumption patterns. The last time India's official poverty line was changed was in 2009 based on the Tendulkar committee recommendations. In 2015, the Rangarajan committee made recommendations updating the poverty lines but it is not clear what their official status is. In fact, India stopped estimating consumption-based poverty after 2011-12 and has been relying in recent times on these World Bank and IMF estimates. India not in consideration As mentioned in the official press release of the Union government, the new IPL reflects (a) revised national poverty lines in low income countries (b) improved measurement of consumption, particularly food and non-food items and (c) the integration of 2021 PPP estimates. In fact, this press note quotes the World Bank saying, 'Most of this upward revision is explained by revisions in the underlying national poverty lines rather than a change in prices'. But the issue is that India is not one of the countries that has made this upward revision to its poverty line! And therefore, the IPL does not include the Indian national poverty line in its consideration at all. While the verdict is out on whether the new methodology of collecting data that was adopted in Household Consumption Expenditure Surveys (HCES) of 2022 and 2023 captures consumption better, what is not in doubt is that this data are now not comparable with the previous rounds of consumption expenditure. While the World Bank has considered the change in the recall period and adjusted for that while comparing with 2011-12 (from URP to MMRP), the HCES changed not just the recall period but the entire way in which data were collected – with multiple visits to each household and changes in the questionnaire. While there have been some validation exercises to understand what the impact of these changes are in comparing trends, no official national estimates have been released so far on what the poverty rates are based on these new surveys. PPP estimates of the ICP are also known to have their methodological issues which are too complex to discuss here. Limitations What is important, however, is to understand the limitations of these global poverty estimates and to be cautious not to assign them more weight than they merit. The World Bank factsheet on the new poverty estimates include FAQs which also clearly explain the limited use of these international poverty ratios by stating: 'A country's national poverty line continues to be far more appropriate for underpinning policy dialogue or targeting programs to reach the poorest within that specific context.' Further, it also states that, 'when analyzing trends for a single country, the national poverty line is the appropriate standard to use. It captures the definition of poverty that is most relevant for this context, as well as how it should be updated over time to reflect changes in survey methodologies and evolving needs.' What is required therefore in India is an urgent exercise at updating our own poverty line – this was something that was under the remit of the erstwhile Planning Commission. The NITI Aayog must now take this on. The expert committee must develop a methodology that robustly measures poverty, grounded in a normative understanding of the basic minimum standards we, as a country, believe every citizen should have access to. In the absence of such an exercise, the old poverty ratios are still being used for making crucial allocations to states for programmes such as the National Social Assistance Programme (NSAP) through which social security pensions for the elderly, single women and disabled are disbursed. Further, it is important to remember that poverty ratios derived from consumption-expenditure-based poverty lines represent only one dimension of well-being. To gain a comprehensive understanding of the realities of people's lives, a broader set of indicators must be considered. These include employment status, real wage trends, health and education outcomes, food security and nutritional status, as well as income and wealth inequality, among others. Taken together, these dimensions provide a more holistic picture of well-being – and on many of these fronts, both national and international estimates indicate that India still has a significant distance to cover. Dipa Sinha is a development economist. The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments. Make a contribution to Independent Journalism Related News Reality Check: Beyond Statistics, is Poverty Actually Reducing in India? Lessons From the BluSmart Case: Why the RBI Must Act Now on Digital Wallets The State of the Economy: India Inc's Profit Dips, Rupee Is Asia's Worst Performer US Cites National Security Grounds, Procedural Errors to Reject India's Notice at WTO World Bank Report on India's Incredible Poverty Reduction Isn't Credible What Happens to the 2026 Football World Cup Under Trump's Travel Ban? Here's to the Humble Bicycle Is RBI's New Plan for Bad Loans Just Another Quick Fix? Sharp Rise in Loan Write-Offs This Fiscal View in Desktop Mode About Us Contact Us Support Us © Copyright. All Rights Reserved.
